NKp46 regulates allergic responses

European Journal of Immunology

Volumn 43, Issue 11, 2013, Pages 3006-3016

  Ghadially, Hormas ^a   Horani, Amjad ^a,b   Glasner, Ariella ^a   Elboim, Moran ^a   Gazit, Roi ^a   Shoseyov, David ^a   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY   (Israel)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Allergy; Dendritic cells; Ncr1; NK cells; NKp46

Indexed keywords

GREEN FLUORESCENT PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 22; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ALLERGIC AIRWAY INFLAMMATION; ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRONCHOSPASM; CELL COUNT; CELL FUNCTION; CELL PROLIFERATION; CONTACT ALLERGY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOREGULATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

ALLERGY; DENDRITIC CELLS; NCR1; NK CELLS; NKP46;

ANIMALS; ANTIGENS, LY; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; GREEN FLUORESCENT PROTEINS; HYPERSENSITIVITY, DELAYED; INFLAMMATION; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; OVALBUMIN; RESPIRATORY HYPERSENSITIVITY; T-LYMPHOCYTES;

EID: 84888020680     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343388     Document Type: Article

References (56)

1. Moretta, L. and Moretta, A., Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J. 2004. 23: 255-259.
2. Hudspeth, K., Silva-Santos, B. and Mavilio, D., Natural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells. Front. Immunol. 2013. 4: 69.
3. Biassoni, R., Pessino, A., Bottino, C., Pende, D., Moretta, L. and Moretta, A., The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity. Eur. J. Immunol. 1999. 29: 1014-1020.
4. Moretta, A., Bottino, C., Mingari, M. C., Biassoni, R. and Moretta, L., What is a natural killer cell? Nat. Immunol. 2002. 3: 6-8.
5. Luci, C., Reynders, A., Ivanov, II, Cognet, C., Chiche, L., Chasson, L. and Hardwigsen, J. et al., Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat. Immunol. 2009. 10: 75-82.
6. Sanos, S. L., Bui, V. L., Mortha, A., Oberle, K., Heners, C., Johner, C. and Diefenbach, A., RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat. Immunol. 2009. 10: 83-91.
7. Weiss, L., Reich, S., Mandelboim, O. and Slavin, S., Murine B-cell leukemia lymphoma (BCL1) cells as a target for NK cell-mediated immunotherapy. Bone Marrow Transplant. 2004. 33: 1137-1141.
8. Sivori, S., Pende, D., Bottino, C., Marcenaro, E., Pessino, A., Biassoni, R., Moretta, L. et al., NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur. J. Immunol. 1999. 29: 1656-1666.
9. Gazit, R., Gruda, R., Elboim, M., Arnon, T. I., Katz, G., Achdout, H., Hanna, J. et al., Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 2006. 7: 517-523.
10. Chaushu, S., Wilensky, A., Gur, C., Shapira, L., Elboim, M., Halftek, G., Polak, D. et al., Direct recognition of Fusobacterium nucleatum by the NK cell natural cytotoxicity receptor NKp46 aggravates periodontal disease. PLoS Pathog. 2012. 8: e1002601.
11. Gur, C., Porgador, A., Elboim, M., Gazit, R., Mizrahi, S., Stern-Ginossar, N., Achdout, H. et al., The activating receptor NKp46 is essential for the development of type 1 diabetes. Nat. Immunol. 2011. 11: 121-128.
12. Gur, C., Enk, J., Kassem, S. A., Suissa, Y., Magenheim, J., Stolovich-Rain, M., Nir, T. et al., Recognition and killing of human and murine pancreatic beta cells by the NK receptor NKp46. J. Immunol. 2011. 187: 3096-3103.
13. Walzer, T., Dalod, M., Robbins, S. H., Zitvogel, L. and Vivier, E., Natural-killer cells and dendritic cells: "l'union fait la force". Blood 2005. 106: 2252-2258.
14. Seidel, E., Glasner, A. and Mandelboim, O., Virus-mediated inhibition of natural cytotoxicity receptor recognition. Cell Mol. Life Sci. 2012. 69: 3911-3920.
15. Vitale, M., Della Chiesa, M., Carlomagno, S., Pende, D., Arico, M., Moretta, L. and Moretta, A., NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 2005. 106: 566-571.
16. Koka, R., Burkett, P., Chien, M., Chai, S., Boone, D. L. and Ma, A., Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells. J. Immunol. 2004. 173: 3594-3598.
17. Lucas, M., Schachterle, W., Oberle, K., Aichele, P. and Diefenbach, A., Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007. 26: 503-517.
18. Spaggiari, G. M., Carosio, R., Pende, D., Marcenaro, S., Rivera, P., Zocchi, M. R., Moretta, L. et al., NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46. Eur. J. Immunol. 2001. 31: 1656-1665.
19. Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M. and Munz, C., Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 2002. 195: 343-351.
20. Ferlazzo, G., Semino, C. and Melioli, G., HLA class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis. Immunol. Lett. 2001. 76: 37-41.
21. Andrews, D. M., Andoniou, C. E., Granucci, F., Ricciardi-Castagnoli, P. and Degli-Esposti, M. A., Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat. Immunol. 2001. 2: 1077-1084.
22. Andoniou, C. E., van Dommelen, S. L., Voigt, V., Andrews, D. M., Brizard, G., Asselin-Paturel, C., Delale, T. et al., Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat. Immunol. 2005. 6: 1011-1019.
23. O'Leary, J. G., Goodarzi, M., Drayton, D. L. and von Andrian, U. H., T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 2006. 7: 507-516.
24. Majewska-Szczepanik, M., Strzepa, A., Drozynska, I., Motyl, S., Banach, T. and Szczepanik, M., Epicutaneous immunization with hapten-conjugated protein antigen alleviates contact sensitivity mediated by three different types of effector cells. Pharmacol. Rep. 2012. 64: 919-926.
25. Bloch, B., The role of idiosyncracy and allergy in dermatology. Arch. Dermat. Syph. 1929. 19: 175-197.
26. Asherson, G. L. and Ptak, W., Contact and delayed hypersensitivity in the mouse. I. Active sensitization and passive transfer. Immunology 1968. 15: 405-416.
27. Kissenpfennig, A. and Malissen, B., Langerhans cells-revisiting the paradigm using genetically engineered mice. Trends Immunol. 2006. 27: 132-139.
28. Brasch, J., Burgard, J. and Sterry, W., Common pathogenetic pathways in allergic and irritant contact dermatitis. J. Invest. Dermatol. 1992. 98: 166-170.
29. Wehner, R., Dietze, K., Bachmann, M. and Schmitz, M., The bidirectional crosstalk between human dendritic cells and natural killer cells. J. Innate Immun. 2011. 3: 258-263.
30. Elboim, M., Gazit, R., Gur, C., Ghadially, H., Betser-Cohen, G. and Mandelboim, O., Tumor immunoediting by NKp46. J. Immunol. 2010. 184: 5637-5644.
31. Arnon, T. I., Achdout, H., Lieberman, N., Gazit, R., Gonen-Gross, T., Katz, G., Bar-Ilan, A. et al., The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. Blood 2004. 103: 664-672.
32. Lutz, M. B., Kukutsch, N., Ogilvie, A. L., Rossner, S., Koch, F., Romani, N. and Schuler, G., An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 1999. 223: 77-92.
33. Rouzaire, P., Luci, C., Blasco, E., Bienvenu, J., Walzer, T., Nicolas, J. F. and Hennino, A., Natural killer cells and T cells induce different types of skin reactions during recall responses to haptens. Eur. J. Immunol. 2012. 42: 80-88.
34. Min-Oo, G., Kamimura, Y., Hendricks, D. W., Nabekura, T. and Lanier, L. L., Natural killer cells: walking three paths down memory lane. Trends Immunol. 2013. 34: 251-258.
35. Lu, L., Ikizawa, K., Hu, D., Werneck, M. B., Wucherpfennig, K. W. and Cantor, H., Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity 2007. 26: 593-604.
36. Waggoner, S. N., Cornberg, M., Selin, L. K. and Welsh, R. M., Natural killer cells act as rheostats modulating antiviral T cells. Nature 2011. 481: 394-398.
37. Van Elssen, C. H., Vanderlocht, J., Oth, T., Senden-Gijsbers, B. L., Germeraad, W. T. and Bos, G. M., Inflammation restraining effects of prostaglandin E2 on natural killer-dendritic cell (NK-DC) interaction are imprinted during DC maturation. Blood 2011. 118: 2473-2482.
38. Tomasello, E., Yessaad, N., Gregoire, E., Hudspeth, K., Luci, C., Mavilio, D., Hardwigsen, J. et al., Mapping of NKp46(+) Cells in healthy human lymphoid and non-lymphoid tissues. Front. Immunol. 2012. 3: 344.
39. Reynders, A., Yessaad, N., Vu Manh, T. P., Dalod, M., Fenis, A., Aubry, C., Nikitas, G. et al., Identity, regulation and in vivo function of gut NKp46+RORgammat+ and NKp46+RORgammat- lymphoid cells. EMBO J. 2011. 30: 2934-2947.
40. Shinagawa, K. and Kojima, M., Mouse model of airway remodeling: strain differences. Am. J. Respir. Crit. Care Med. 2003. 168: 959-967.
41. Gumy, A., Louis, J. A. and Launois, P., The murine model of infection with Leishmania major and its importance for the deciphering of mechanisms underlying differences in Th cell differentiation in mice from different genetic backgrounds. Int. J. Parasitol. 2004. 34: 433-444.
42. Kodama, M., Asano, K., Oguma, T., Kagawa, S., Tomomatsu, K., Wakaki, M., Takihara, T. et al., Strain-specific phenotypes of airway inflammation and bronchial hyperresponsiveness induced by epicutaneous allergen sensitization in BALB/c and C57BL/6 mice. Int. Arch. Allergy Immunol. 2010. 152(Suppl 1): 67-74.
43. Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J. and Hill, A. M., M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 2000. 164: 6166-6173.
44. Asselin-Paturel, C., Brizard, G., Pin, J. J., Briere, F. and Trinchieri, G., Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J. Immunol. 2003. 171: 6466-6477.
45. Flacher, V., Douillard, P., Ait-Yahia, S., Stoitzner, P., Clair-Moninot, V., Romani, N. and Saeland, S., Expression of langerin/CD207 reveals dendritic cell heterogeneity between inbred mouse strains. Immunology 2008. 123: 339-347.
46. Condon, T. V., Sawyer, R. T., Fenton, M. J. and Riches, D. W., Lung dendritic cells at the innate-adaptive immune interface. J. Leukoc. Biol. 2011. 90: 883-895.
47. Toebak, M. J., Gibbs, S., Bruynzeel, D. P., Scheper, R. J. and Rustemeyer, T., Dendritic cells: biology of the skin. Contact Dermatitis 2009. 60: 2-20.
48. Randolph, G. J., Inaba, K., Robbiani, D. F., Steinman, R. M. and Muller, W. A., Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 1999. 11: 753-761.
49. Kool, M., Soullie, T., van Nimwegen, M., Willart, M. A., Muskens, F., Jung, S., Hoogsteden, H. C. et al., Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J. Exp. Med. 2008. 205: 869-882.
50. Narni-Mancinelli, E., Jaeger, B. N., Bernat, C., Fenis, A., Kung, S., De Gassart, A., Mahmood, S. et al., Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses. Science 2012. 335: 344-348.
51. Eckelhart, E., Warsch, W., Zebedin, E., Simma, O., Stoiber, D., Kolbe, T., Rulicke, T. et al., A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. Blood 2011. 117: 1565-1573.
52. Horani, A., Shoseyov, D., Doron, S., Mruwat, R., Amer, J., Kerem, E. and Safadi, R., Immune modulation of ovalbumin-induced lung injury in mice using beta-glucosylceramide and a potential role of the liver. Immunobiology 2011. 216: 548-557.
53. Hamelmann, E., Schwarze, J., Takeda, K., Oshiba, A., Larsen, G. L., Irvin, C. G. and Gelfand, E. W., Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit. Care Med. 1997. 156: 766-775.
54. Birnberg, T., Bar-On, L., Sapoznikov, A., Caton, M. L., Cervantes-Barragan, L., Makia, D., Krauthgamer, R. et al., Lack of conventional dendritic cells is compatible with normal development and T cell homeostasis, but causes myeloid proliferative syndrome. Immunity 2008. 29: 986-997.
55. Gur, C., Porgador, A., Elboim, M., Gazit, R., Mizrahi, S., Stern-Ginossar, N., Achdout, H. et al., The activating receptor NKp46 is essential for the development of type 1 diabetes. Nat. Immunol. 2010. 11: 121-128.
56. Stern-Ginossar, N., Saleh, N., Goldberg, M. D., Prichard, M., Wolf, D. G. and Mandelboim, O., Analysis of human cytomegalovirus-encoded microRNA activity during infection. J. Virol. 2009. 83: 10684-10693.